Publications
-
- Paper publication
- GPR119 activation by DA-1241 alleviates hepatic and systemic inflammation in MASH mice through inhibition of NFκB signaling. Biomed Pharmacother. 2023 Aug 30;166:115345. doi: 10.1016/j.biopha.2023.115345. PMID: 37657264Lee SH, Park H, Yang EK, Lee BR, Jung IH, Kim TH, Goo MJ, Chae Y, Kim MK.
-
- Paper publication
- DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice. Diabetes Metab J. 2022 Mar;46(2):337-348. doi: 10.4093/dmj.2021.0056. PMID: 35052026Kim Y, Lee SW, Wang H, Kim RH, Park HK, Lee H, Kang ES.
-
- Paper publication
- A novel GPR119 agonist DA-1241 preserves pancreatic function via the suppression of ER stress and increased PDX1 expression. Biomed Pharmacother. 2021 Dec;144:112324. doi: 10.1016/j.biopha.2021.112324. Epub 2021 Oct 19. PMID: 34678732.Kim MK, Cheong YH, Lee SH, Kim TH, Jung IH, Chae Y, Lee JH, Yang EK, Park H, Yang JS, Hong KW.